In ME/CFS, a set of plasma miRNAs known to modulate the Sirt1/eNOS axis were analysed, showing elevation in miR-21, miR-34a, miR-92a, miR-126, and miR-200c (305)
revealed that the cyclin-dependent kinase (Cdk) inhibitor p21 Waf1/Cip1/Sdi1 lack stable secondary or tertiary structure in the free solution state, but its N-terminal region adopts an ordered stable conformation when bound to Cdk2, thereby providing a mechanical explanation to the remarkable ability of p21 Waf1/Cip1/Sdi1 to bind and inhibit a diverse family of cyclin-Cdk complexes, including cyclin A-Cdk2, cyclin E-Cdk2, and cyclin D-Cdk4 (Kriwacki et al., 1996)
While preclinical studies support this hypothesis, robust clinical evidence remains limited
Does NOT induce Insulin Resistance: It has no effect on blood glucose or insulin sensitivity
10.1007/s40265-015-0489-4 51 WenP.SunZ.GouF.WangJ.FanQ.ZhaoD.et al (2025)